Why the study?
Does aspirin increase coronary collateral flow after acute coronary occlusion in dogs?
Does aspirin increase coronary collateral flow after acute coronary occlusion in dogs?
Aspirin administration prior to acute coronary occlusion in dogs significantly increases epicardial collateral blood flow over 4 hours.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications for acute coronary syndromes; leaves open whether aspirin enhances epicardial collaterals in humans.
Aspirin (acetylsalicylic acid) has inhibitory effects on platelet function and prostaglandin synthesis. Since alterations in either platelet function or prostaglandin-mediated vascular responses could influence blood flow to ischemic myocardium, we tested the effects of aspirin on coronary collateral flow after acute occlusion of the left anterior descending coronary artery in dogs. Aspirin dose (600 mg i.v.) consistently inhibited in vitro ADP-induced platelet aggregation. In 13 open-chest dogs, regional myocardial blood flows (radioactive microsphere technique) were determined at 5 minutes and 4 hours after occlusion). In seven of these dogs, aspirin (600 mg i.v.) was administered 1 hour before occlusion. In the aspirin-treated dogs, collateral flow increased significantly (p less than 0.05), from 0.09 +/- 0.02 ml/min/g at 5 minutes to 0.15 and 0.02 ml/min/g 4 hours after occlusion. Collateral flow was not significantly altered over 4 hours in control dogs. The aspirin-induced increase in collateral flow was confined to epicardium (12 +/- 4% of normal zone flow at 5 minutes to 23 +/- 4% at 4 hours after occlusion).
No takes yet. Share an insight, caveat, or question.
Capurro et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: